| (210) | Number of the EPO application | 16729739 |
| (220) | Filing date of the EPO application | 2016.06.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 01/2021, 2021.01.06 |
| (110) | EPO patent number | 3302440 |
| (21) | Number of the application | e 2018 0335 |
| (71) | Name(s) of applicant(s), code of the country | Ironwood Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | HASHASH Ahmad, US; |
| (73) | Name(s) of owner(s), code of the country | IRONWOOD Pharmaceuticals Inc., US; |
| (54) | Title of the invention | MODIFIED OR TARGETED RELEASE FORMULATIONS OF LINACLOTIDE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61K 9/28 (2006.01.01); A61K 38/10 (2006.01.01); A61P 1/00 (2006.01.01); A61P 29/02 (2006.01.01); A61P 13/10 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.05.31 |
| (30) | Priority | 201562171462 P, 2015.06.05, US; 201662339462 P, 2016.05.20, US |
| (86) | International application | PCT/US2016/035886, 2016.06.03 |
| (87) | International publication | WO 2016/197042, 2016.12.08 |